Literature DB >> 11027564

Expression of integrated hepatitis B virus X variants in human hepatocellular carcinomas and its significance.

W N Chen1, C J Oon, A L Leong, S Koh, S W Teng.   

Abstract

Hepatitis B virus X protein (HBX) has been implicated in the transactivation of diverse cellular genes and possibly also the pathogenesis of human hepatocellular carcinoma (HCC). We report the characterization of HBX variants from HBV-related human hepatocellular carcinoma (HCC). These HBX variants were integrated into the host chromosomes and also expressed in the HCC tissues. In addition, we report a novel in vitro HBX activity assay based on color changes that were indicative of the beta-galactosidase enzyme activity. Conducted in wheat germ lysates, the transactivating function of either wild type or mutant HBX protein was measured through their interaction with the Early Growth Response factor 1 (Egr-1) that controls the beta-galactosidase gene. Further analysis of these HBX deletion mutants using this assay may shed new insights on the significance of various mutations occurring in HCC-associated HBX. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11027564     DOI: 10.1006/bbrc.2000.3562

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Applying a highly specific and reproducible cDNA RDA method to clone garlic up-regulated genes in human gastric cancer cells.

Authors:  Yong Li; You-Yong Lu
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

2.  Hepatitis B virus X protein in the proteasome of mammalian cells: defining the targeting domain.

Authors:  W N Chen; C J Oon; K S Goo
Journal:  Mol Biol Rep       Date:  2001-03       Impact factor: 2.316

3.  Cooperation of tumor-derived HBx mutants and p53-249(ser) mutant in regulating cell proliferation, anchorage-independent growth and aneuploidy in a telomerase-immortalized normal human hepatocyte-derived cell line.

Authors:  Weidong Jiang; Xin Wei Wang; Tamar Unger; Marshonna Forgues; Jin Woo Kim; S Perwez Hussain; Elise Bowman; Elisa A Spillare; Michael M Lipsky; Jeanne M Meck; Luciane R Cavalli; Bassem R Haddad; Curtis C Harris
Journal:  Int J Cancer       Date:  2010-09-01       Impact factor: 7.396

4.  siRNA pool targeting different sites of human hepatitis B surface antigen efficiently inhibits HBV infection.

Authors:  Yong Chen; Ram I Mahato
Journal:  J Drug Target       Date:  2008-02       Impact factor: 5.121

5.  Repeated passage of wild-type woodchuck hepatitis virus in lymphoid cells does not generate cell type-specific variants or alter virus infectivity.

Authors:  Patricia M Mulrooney-Cousins; Tomasz I Michalak
Journal:  J Virol       Date:  2008-05-21       Impact factor: 5.103

6.  A novel mutant 10Ala/Arg together with mutant 144Ser/Arg of hepatitis B virus X protein involved in hepatitis B virus-related hepatocarcinogenesis in HepG2 cell lines.

Authors:  Ying Shi; Junwei Wang; Yuhe Wang; Anna Wang; Hongliang Guo; Feili Wei; Sanjay R Mehta; Stephen Espitia; Davey M Smith; Longgen Liu; Yulin Zhang; Dexi Chen
Journal:  Cancer Lett       Date:  2015-12-17       Impact factor: 8.679

7.  Molecular characterization of hepatitis B virus X gene in chronic hepatitis B patients.

Authors:  Luciana Barbini; Luciana Tadey; Silvina Fernandez; Belen Bouzas; Rodolfo Campos
Journal:  Virol J       Date:  2012-07-08       Impact factor: 4.099

8.  The effect of miR-338-3p on HBx deletion-mutant (HBx-d382) mediated liver-cell proliferation through CyclinD1 regulation.

Authors:  Xiaoyu Fu; Deming Tan; Zhouhua Hou; Zhiliang Hu; Guozhen Liu; Yi Ouyang; Fei Liu
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

9.  Contribution of C1485T mutation in the HBx gene to human and murine hepatocarcinogenesis.

Authors:  Satoru Hagiwara; Naoshi Nishida; Ah-Mee Park; Yoriaki Komeda; Toshiharu Sakurai; Tomohiro Watanabe; Masatoshi Kudo
Journal:  Sci Rep       Date:  2017-09-05       Impact factor: 4.379

10.  HBX-mediated migration of HBV-replicating HepG2 cells: insights on development of hepatocellular carcinoma.

Authors:  Huixing Feng; Jianhua Zhang; Xi Li; Wei Ning Chen
Journal:  J Biomed Biotechnol       Date:  2009-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.